The role of chemotherapy in patients with stage IB gastric adenocarcinoma: a real-world competing risk analysis

The role of chemotherapy in patients with stage IB gastric adenocarcinoma: a real-world competing risk analysis

Abstract Background This study aimed to investigate the potential effect of adjuvant chemotherapy in patients diagnosed with stage IB gastric adenocarcinoma (GAC). Method A total of 1727 patients were included in the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2015 and d...

Full description

Bibliographic Details
Main Authors:	Yangyang Xie, Danwei Du, Xue Song, Xiaowen Li, Zhongkai Ni, Hai Huang
Format:	Article
Language:	English
Published:	BMC 2022-04-01
Series:	World Journal of Surgical Oncology
Subjects:	Stage IB gastric cancer Chemotherapy Competing risk analysis
Online Access:	https://doi.org/10.1186/s12957-022-02591-5

Similar Items

A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage IB gastric adenocarcinoma
by: Yangyang Xie, et al.
Published: (2023-03-01)

De-escalating chemotherapy for stage I–II gastric neuroendocrine carcinoma? A real-world competing risk analysis
by: Danwei Du, et al.
Published: (2023-05-01)

Association of survival with adjuvant chemotherapy in patients with stage IB gastric cancer: a multicentre, observational, cohort studyResearch in context
by: Xianchun Gao, et al.
Published: (2024-04-01)

A case of successful maintained pregnancy after neoadjuvant chemotherapy plus radical surgery for stage IB3 cervical cancer diagnosed at 13 weeks
by: Ying Guo, et al.
Published: (2020-04-01)

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma
by: Po-Hsin Lee, et al.
Published: (2023-02-01)

Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis
by: Ke Zhou, et al.
Published: (2022-08-01)

Clinical efficacy and safety of adjuvant EGFR‐TKIs for resected stage IB lung adenocarcinoma: A real‐world study based on propensity score matching
by: Leilei Shen, et al.
Published: (2023-09-01)

History and emerging trends in chemotherapy for gastric cancer
by: Keishi Yamashita, et al.
Published: (2021-07-01)

Research for Mediastinal Lymph Node Desection Style of Stage Ib  Upper Lobe Non-small Cell Lung Cancer
by: Wenli WANG, et al.
Published: (2013-11-01)

Prognostic factors and the necessity of chemotherapy for stage II gastric cancer: a model based on multicenter retrospective study
by: Jiaming Fang, et al.
Published: (2023-05-01)

Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion
by: Zegang Ruan, et al.
Published: (2024-01-01)

Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
by: Jenny Ling-Yu Chen, et al.
Published: (2021-03-01)

MANEJO DEL CÁNCER CERVICOUTERINO IB2-IIA
by: José A Solis C
Published: (2004-01-01)

Deep muscularis propria tumor invasion without lymph node metastasis as a unique subclassification of stage IB gastric cancer: a retrospective study
by: Kang He, et al.
Published: (2022-01-01)

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
by: Bonomi Maria, et al.
Published: (2011-12-01)

Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual
by: Lei-Lei Wu, et al.
Published: (2020-04-01)

Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trialResearch in context
by: Wei Ou, et al.
Published: (2023-03-01)

Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
by: Annamaria Altomare, et al.
Published: (2021-04-01)

Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
by: Fang Zhou, et al.
Published: (2022-09-01)

Prognostic factors of T2aN0M0 (T3‐4cmN0M0, stage IB) non‐small‐cell lung cancer after surgery: Single‐center real‐world research
by: Lei Liu, et al.
Published: (2021-12-01)

Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma
by: Shuhui Cao, et al.
Published: (2019-02-01)

IbOr Regulates Photosynthesis under Heat Stress by Stabilizing IbPsbP in Sweetpotato
by: Le Kang, et al.
Published: (2017-06-01)

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
by: Xiangqing Ren, et al.
Published: (2023-08-01)

Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer
by: Keiji Nishibeppu, et al.
Published: (2018-01-01)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
by: Jiao-Bao Huang, et al.
Published: (2021-08-01)

CANCER CERVICOUTERINO EN ESTADIO IB2: TRATAMIENTO CON RADIOQUIMIOTERAPIA CONCOMITANTE Y CIRUGIA
by: Ricardo San Martín T., et al.
Published: (2003-01-01)

Conversion Surgery for Stage IV Gastric Cancer
by: Fei Zhang, et al.
Published: (2019-11-01)

Implication of perineural invasion in patients with stage II gastric cancer
by: Dandong Luo, et al.
Published: (2023-11-01)

Effectiveness of post-mastectomy adjuvant chemotherapy for the treatment of patients with prognostic stage IB breast cancer: A SEER-based study
by: HongMei Wang, et al.
Published: (2023-09-01)

Somatic mutation of DNAH genes implicated higher chemotherapy response rate in gastric adenocarcinoma patients
by: Chunchao Zhu, et al.
Published: (2019-04-01)

Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?
by: Albouzidi Abderrahmane, et al.
Published: (2011-09-01)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
by: Jianping Guo, et al.
Published: (2023-10-01)

NCGS like IBS ‘type’ symptoms is a diagnosis of exclusion
by: H. Ahmed, et al.
Published: (2021-09-01)

Clinical Outcome of Primary Gastric Lymphoma Treated with Chemotherapy Alone or Surgery Followed by Chemotherapy
by: Ming-Chih Chang, et al.
Published: (2006-01-01)

Perioperative Chemotherapy with FLOT Scheme in Resectable Gastric Adenocarcinoma: A Preliminary Correlation between TRG and Radiomics
by: Giovanni Maria Garbarino, et al.
Published: (2021-10-01)

Perioperative chemotherapy for gastric cancer: the current state
by: V K Lyadov, et al.
Published: (2018-06-01)

A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial
by: Xin Wu, et al.
Published: (2022-04-01)

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
by: Christina Hadzitheodorou, et al.
Published: (2017-04-01)

Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data
by: Tae-Hwan Kim, et al.
Published: (2021-03-01)

Clinicopathologial features of gastric hepatoid adenocarcinoma
by: Cheng-Yu Lin, et al.
Published: (2015-02-01)